Data gathered: November 2
Alternative Data for China Pharma Holding
Alternative Data | Value | 3m Change | Trend | Benchmark | |
---|---|---|---|---|---|
Sentiment | 100 | Sign up | Sign up | Sign up | |
Webpage traffic | 1,000 | Sign up | Sign up | Sign up | |
Google Trends | N/A | Sign up | Sign up | Sign up | |
Patents | N/A | Sign up | Sign up | Sign up | |
4chan Mentions | N/A | Sign up | Sign up | Sign up | |
Reddit Mentions | N/A | Sign up | Sign up | Sign up | |
Stocktwits Mentions | 15 | Sign up | Sign up | Sign up | |
Stocktwits Subscribers | 14,071 | Sign up | Sign up | Sign up | |
Twitter Mentions | 22 | Sign up | Sign up | Sign up | |
News Mentions | N/A | Sign up | Sign up | Sign up | |
Customer reviews | N/A | Sign up | Sign up | Sign up |
About China Pharma Holding
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China.
Price | $0.26 |
Target Price | Sign up |
Volume | 506,580 |
Market Cap | $4.4M |
Year Range | $0.18 - $0.44 |
Dividend Yield | 0% |
Analyst Rating | 0% buy |
Industry | Biotechnology |
In the news
China Pharma Holdings, Inc. expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025August 18 - Yahoo |
|
CPHI Stock Earnings: China Pharma Holding Reported Results for Q2 2024August 16 - Biztoc.com |
|
CPHI Stock Earnings: China Pharma Holding Reported Results for Q1 2024May 20 - Biztoc.com |
|
12 Health Care Stocks Moving In Wednesday's After-Market SessionOctober 1 - Benzinga |
|
China Pharma expects to launch dry eye disease therapeutic device in Q1August 18 - Seeking Alpha |
|
China Pharma subsidiary plans to launch dry eye treatment in Q1 of 2025 in ChinaAugust 18 - Thefly.com |
Financial performance View All
Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
---|---|---|---|---|---|---|
Q2 '24 | 920,000 | 1.9M | -1M | -1.4M | -1.3M | -0.089 |
Q1 '24 | 1.4M | 1.7M | -290,000 | -960,000 | -820,000 | -0.073 |
Q4 '23 | 2.1M | 2.2M | -79,000 | -1.2M | -1.1M | -0.116 |
Q3 '23 | 1.8M | 2M | -230,000 | -780,000 | -660,000 | -0.294 |
Q2 '23 | 1.1M | 1.2M | -150,000 | -590,000 | -400,000 | -0.299 |
Insider Transactions View All
No recorded Insider transactions.
Similar companies
Read more about China Pharma Holding (CPHI) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, sentiment, webpage traffic, google trends, patents, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions & customer reviews.
What is the Market Cap of China Pharma Holding?
The Market Cap of China Pharma Holding is $4.4M.
What is the current stock price of China Pharma Holding?
Currently, the price of one share of China Pharma Holding stock is $0.26.
How can I analyze the CPHI stock price chart for investment decisions?
The CPHI stock price chart above provides a comprehensive visual representation of China Pharma Holding's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling China Pharma Holding shares. Our platform offers an up-to-date CPHI stock price chart, along with technical data analysis and alternative data insights.
Does CPHI offer dividends to its shareholders?
As of our latest update, China Pharma Holding (CPHI) does not offer dividends to its shareholders. Investors interested in China Pharma Holding should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of China Pharma Holding?
Some of the similar stocks of China Pharma Holding are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.